Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001829126-25-004015·Avenue Venture Opportunities Fund II, L.P.
Schedule 13G ownership disclosure
CALCIMEDICA INC
Common Stock, par value $0.0001 per share · CUSIP: 38942Q202
Event date: 2025-02-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Avenue Venture Opportunities Fund II, L.P.
Shares: 1,000,358.00 · Class: 6.7%
- Avenue Capital Management II, L.P.
Shares: 1,000,358.00 · Class: 6.7%
- Avenue Venture Opportunities Partners II, LLC
Shares: 1,000,358.00 · Class: 6.7%
- GL Venture Opportunities Partners II, LLC
Shares: 1,000,358.00 · Class: 6.7%
- Marc Lasry
Shares: 1,000,358.00 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-25-004015
- Form type
- SCHEDULE 13G
- Filer
- Avenue Venture Opportunities Fund II, L.P.
- CIK
- CIK 1886343
- Filed
- May 28, 2025
- Reporting period
- Feb 28, 2025
- Description
- Schedule 13G beneficial ownership